
Our medical experts are ready to answer your questions and guide you through your treatment options.
For patients in Iraq facing complex cancer diagnoses, finding advanced treatment options like Immunotherapy and CAR-T Cell Therapy can feel overwhelming. Concerns about treatment quality, access to expertise, and overall cost often add to the emotional burden.
Many seek care beyond their borders, and Mumbai stands out as a leading destination. The city offers world-class oncology centers specializing in these innovative therapies, providing a focused environment for highly specialized care.
Mumbai's medical infrastructure is built on experienced oncology teams and state-of-the-art facilities. Patients benefit from coordinated care, allowing for smoother transitions from initial consultation to advanced treatment and essential follow-up.
Could Mumbai be the right choice for your Immunotherapy or CAR-T Cell Therapy journey?
Immunotherapy and CAR-T Cell Therapy represent cutting-edge approaches in cancer treatment that harness the body's own immune system. Immunotherapy works by boosting or modifying the immune system to recognize and attack cancer cells. This can involve drugs that remove "brakes" on immune cells (checkpoint inhibitors) or introduce lab-made antibodies. CAR-T Cell Therapy is a more personalized immunotherapy where a patient’s T-cells are genetically engineered in a lab to produce chimeric antigen receptors (CARs). These CARs allow the T-cells to identify and destroy specific cancer cells when reinfused into the patient. Both aim to provide highly targeted and often more effective treatment with fewer side effects than traditional chemotherapy.
These drugs block proteins that prevent immune cells from attacking cancer, essentially releasing the "brakes" on the immune system.
Lab-produced antibodies that target specific cancer cell proteins, marking them for destruction by the immune system or directly interfering with their growth.
Viruses engineered to infect and destroy cancer cells while leaving healthy cells unharmed, also stimulating an immune response against the tumor.
Currently, the most established application involves modifying a patient's T-cells to target specific markers on B-cell cancers, leading to profound responses.
Research continues into CAR-T therapies for solid tumors and other hematologic malignancies, expanding the potential reach of this advanced treatment.
The specific procedure for Immunotherapy and CAR-T Cell Therapy varies based on the type of therapy, cancer condition, and individual patient plan.
Immunotherapy drugs are typically given intravenously (IV) through a vein. This process usually takes place in an outpatient clinic or hospital infusion center. The frequency and duration of infusions depend on the specific drug and treatment protocol, ranging from once every few weeks to several months.
This advanced therapy involves several key steps. First, blood is collected from the patient through a process called leukapheresis, similar to donating blood, to harvest T-cells. These T-cells are then sent to a specialized lab where they are genetically modified to express CARs that target cancer cells. After modification and expansion, millions of these CAR-T cells are frozen and sent back to the hospital. Before reinfusion, the patient typically undergoes a short course of chemotherapy to reduce existing immune cells. Finally, the modified CAR-T cells are infused back into the patient, usually requiring hospitalization for close monitoring due to potential side effects.
Recovery from Immunotherapy is often gradual, with side effects managed through medication and monitoring. Patients can usually return to daily activities relatively quickly, but ongoing fatigue or other immune-related side effects might persist. For CAR-T Cell Therapy, the initial recovery involves a hospital stay of several weeks, crucial for monitoring severe side effects like cytokine release syndrome (CRS) or neurotoxicity. After hospital discharge, patients require close outpatient follow-up for several months, often involving weekly appointments. Long-term follow-up is essential to monitor for relapse, manage late-onset side effects, and ensure ongoing well-being. Rehabilitation and supportive care are often integrated into the recovery plan.
The success rates for Immunotherapy and CAR-T Cell Therapy vary widely based on the type of cancer, its stage, the patient’s overall health, and prior treatments. For certain leukemias and lymphomas, CAR-T Cell Therapy can achieve complete remission rates of 40-70% in patients who have exhausted other options. Immunotherapy has also shown remarkable, durable responses in various advanced cancers, extending survival significantly for a subset of patients. Outcomes are influenced by how the individual's immune system responds to the therapy, and ongoing research aims to further improve these results and predict patient responses more accurately.
The cost of Immunotherapy and CAR-T Cell Therapy in Mumbai can vary significantly. Factors influencing the total expenditure include the specific type of therapy chosen, the duration of treatment, the hospital's infrastructure and reputation, the specialist's fees, and the need for additional supportive care or management of side effects. Diagnostic tests, hospital stay duration, and post-treatment medications also contribute to the overall cost.
A broad estimate for Immunotherapy could range from INR 4,00,000 to INR 25,00,000+ per cycle, while CAR-T Cell Therapy typically starts from INR 2,00,00,000 to INR 4,00,00,000+ (approximately 240,000 to 480,000 USD) for the entire procedure, depending on the specific product and patient needs.
Mumbai offers a significantly more affordable option for Immunotherapy and CAR-T Cell Therapy compared to many Western countries, often without compromising on quality or advanced technology.
| Location | Immunotherapy (per cycle) | CAR-T Cell Therapy (full procedure) |
|---|---|---|
| Mumbai, India | $5,000 - $30,000 | $240,000 - $480,000 |
| United States | $15,000 - $50,000+ | $500,000 - $1,000,000+ |
| United Kingdom | $10,000 - $40,000 | $350,000 - $700,000 |
| Germany | $8,000 - $35,000 | $300,000 - $600,000 |
| Singapore | $7,000 - $30,000 | $280,000 - $550,000 |
Our patient support team is ready to assist you. Get a personalized cost estimate and connect with leading oncology specialists in Mumbai.
Considering Immunotherapy or CAR-T Cell Therapy in Mumbai for cancer treatment is a significant decision. Accessing world-class care and advanced therapies could open new avenues for your health.
Reach out to us for a free consultation. Let us help you navigate your treatment options and make informed choices for your health journey.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.